Empaveli 1080 MG
Ended Awarded
- Contract number
- 36C24524N0130
- Awardee
-
APL Sales I LLC UEI XXKJSCZRL266 Part of Apellis Pharmaceuticals, Inc.
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $25,507
Award facts
- Contract value 100% obligated
- $25,506.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration awarded a $25,506.96 delivery order contract to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc., to provide EMPAVELI 1080 MG. The contract was awarded against Apellis Pharmaceuticals' Pharmaceuticals and Drugs GSA Schedule contract with the parent agency. Performance will take place in Pittsburgh, PA over a two-day period in early November 2023. The firm fixed price contract is intended to deliver EMPAVELI, a complement C3 inhibitor approved to treat patients with paroxysmal nocturnal hemoglobinuria. No subcontractors or set aside designations were identified. The VHA award will support the integrated healthcare network's treatment of eligible veterans through its regional VISN 5 location.
Quick answers
Who was awarded contract 36C24524N0130?
36C24524N0130 was awarded to APL Sales I LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 1, 2023.
How much is contract 36C24524N0130 worth?
The government has obligated $25,507 on 36C24524N0130.
Is contract 36C24524N0130 an order under another contract?
Yes. 36C24524N0130 is a delivery order under 36F79722D0039, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0130 competed?
The extent of competition for 36C24524N0130 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award